Sign In
Buy IOVA
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
12:30pm, Monday, 19'th May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ:IOVA). Such inve
LOS ANGELES--(BUSINESS WIRE)--Law Offices of Frank R. Cruz Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors To Inquire About Securities Fraud Class Action.
Investors in Iovance Biotherapeutics, Inc. (IOVA): Protect Your Rights - Contact Levi & Korsinsky Before July 14, 2025
11:45am, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
IOVA Investors Have Opportunity to Lead Iovance Biotherapeutics, Inc. Securities Fraud Lawsuit
11:25am, Monday, 19'th May 2025
NEW YORK , May 19, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Iovance Biotherapeutics, Inc. (N
Did You Lose Money on Iovance Biotherapeutics, Inc. (IOVA)? Levi & Korsinsky Urges Investors to Act Before July 14, 2025
07:15am, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iovance
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline
11:30pm, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Iovance Biotherapeutics
Levi & Korsinsky Urges Iovance Biotherapeutics, Inc. (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025
04:25pm, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Over Securities Violations - Contact Levi & Korsinsky Today
09:00am, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
IOVA Investors Have the Opportunity to Lead the Iovance Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
08:47am, Sunday, 18'th May 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Iovance To Contact Him Directly To Discuss Their Options
Iovance Biotherapeutics, Inc. (IOVA) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 14, 2025 Deadline
07:07am, Sunday, 18'th May 2025
NEW YORK, NY / ACCESS Newswire / May 18, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK CITY, NY / ACCESS Newswire / May 18, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iovance
Class Action Alert: Levi & Korsinsky Reminds Iovance (IOVA) Investors of July 14, 2025 Deadline
06:01pm, Saturday, 17'th May 2025
NEW YORK, NY / ACCESS Newswire / May 17, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Iovance Shareholders Should Contact Shareholder Rights Firm Regarding Potential Legal Claims
08:00am, Saturday, 17'th May 2025
NEW YORK , May 17, 2025 /PRNewswire/ -- Julie & Holleman LLP, a top-tier shareholder rights firm, is investigating potential claims against Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) and its exec
